News
08-19-2011, 01:10 AM
DiaGenic: Important milestones achieved. DiaGenic's collaboration with Pfizer is the first collaboration between a diagnostics company and the market leader for Alzheimer's therapeutics that aims to identify blood based diagnostic tools that can detect early Alzheimer's disease, before the disease is clinically overt, or accessible to other either more invasive and costly or less precise diagnostic exploration.
More... (http://www.news-medical.net/news/20110819/DiaGenic-reports-operating-revenue-of-NOK-1151-thousand-for-second-quarter-2011.aspx)
More... (http://www.news-medical.net/news/20110819/DiaGenic-reports-operating-revenue-of-NOK-1151-thousand-for-second-quarter-2011.aspx)